SL McAfee - Concepedia

Author

SL McAfee

Massachusetts General Hospital

Also Known As

S L McAfee, S McAfee, S. McAfee, S.L. McAfee, SL McAfee

Publications

425

Citations

H-Index

Concepts

All Affiliations

Massachusetts General Hospital Harvard University Boston University

About

SL McAfee is an author at Massachusetts General Hospital specializing in medicine, transplantation, and marrow transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	366
2	Blood Transplantation	2	2	100
3	Cell Biology	2	2	44
4	Cellular Therapies	2	2	53
5	Health Sciences	1	1	81

SL McAfee

Publications

402

Citations

H-Index

Page 1

	Year	Citations
A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation Christine Colby, SL McAfee, Robert Sackstein, Bone Marrow Transplantation Drug SafetyPharmacologyToxicologyPharmacotherapyMedicine	1999	100
Prognostic understanding, quality of life and mood in patients undergoing hematopoietic stem cell transplantation Areej El‐Jawahri, Luke Traeger, Kailyn Kuzmuk, Bone Marrow Transplantation Quality Of LifeLife SatisfactionTransplantationMarrow TransplantationPsychiatry	2015	81
Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation HC Toh, SL McAfee, Robert Sackstein, Bone Marrow Transplantation TransplantationMedicineStem Cell TransplantationPathologyVeno-occlusive Disease	1999	73
Phase I-II trial of high-dose cyclophosphamide, carboplatin and autologous bone marrow or peripheral blood stem cell rescue. Spitzer Tr, E Cirenza, SL McAfee, PubMed	1995	36
Expression of α4β7 integrin on memory CD8+ T cells at the presentation of acute intestinal GVHD Y-B Chen, Sean M. McDonough, H Chen, Bone Marrow Transplantation MedicineImmunologyImmune RegulationImmunologic MechanismAntigen Processing	2012	28
Early vs delayed administration of G-CSF following autologous peripheral blood stem cell transplantation Christine Colby, SL McAfee, DM Finkelstein, Bone Marrow Transplantation Regenerative MedicineCell TherapyTransplantationMarrow TransplantationStem Cell Transplantation	1998	27
High-dose carboplatin and regimen-related toxicity following autologous bone marrow transplant Christine Colby, S Koziol, SL McAfee, Bone Marrow Transplantation Hematological MalignancyCell TherapyTransplantationOncologyMarrow Transplantation	2002	26
High-dose cyclophosphamide + carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma – a phase II study HC Toh, SL McAfee, Robert Sackstein, Bone Marrow Transplantation Breast OncologyTransplantationMedicineImmunologyPhase Ii Study	2000	16
Autologous SCT with a dose-reduced BU and CY regimen in older patients with non-Hodgkin's lymphoma Rukh Yusuf, B Dey, B.Y. Yeap, Bone Marrow Transplantation Hematological MalignancyLymphoid NeoplasiaOncologyAutologous SctPathology	2008	15

Page 1